Andre Ulloa of M&A Healthcare Advisors discusses healthcare M&A trends in the November 2021 issue of Home Health Line.
“We anticipate the home health market will remain just as active as we have seen over the last year,” says Andre Ulloa, partner/executive advisor with M&A Healthcare Advisors in Calabasas, Calif.
Axial | Cheryl Meyer
Healthcare M&A activity has seen a hearty uptick this year, making it an attractive — and exhausting — space for advisors bent on helping sellers pilot through the complicated deal-making process.
Los Angeles-based Mark Thomas, Mike Moran, and Andre Ulloa, who worked together for years in a similar capacity, seized the opportunity this fall to launch their own sell-side advisory firm, M&A Healthcare Advisors. Within only five weeks of operation they were busy guiding several sell-side clients in the healthcare realm. Two of these clients operate in the behavioral health sector, and the firm’s sweet spot is aiding companies generating $100 million or less in revenue, noted Thomas, a partner and the firm’s director of operations. The firm also offers hourly consulting services and performs expert valuations and witness testimony, though sell-side representation is its primary focus.
“The fact that we have a number of sell-side clients in our first five weeks is telling for a variety of reasons,” stated Moran, partner, executive advisor, and the firm’s behavioral health specialist. The booming healthcare M&A market, much like the competitive housing market, is allowing sellers to lure numerous buyers to the table. “To us client is king, and multiple offers are a way to drive these businesses above market norms,” he said.
